Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million on June 6, 2024. A cash consideration of INR 330 million will be paid by Sun Pharmaceutical Industries Limited. As part of consideration, INR 330 million is paid towards common equity of HaystackAnalytics Pvt. Ltd.

The deal is expected to be completed by July, 2024 subject to satisfactory completion of certain conditions.